I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
You, Maojin
28
results:
Search for persons
X
Format
Online (28)
Mediatypes
Articles (Online) (12)
OpenAccess-fulltext (16)
Sorted by: Year
Sorted by: Relevance
?
1
Toroidal dipole bound states in the continuum in all-dielec..:
Guo, Linhui
;
Zhang, Zexuan
;
Xie, Qun
...
Applied Surface Science. 615 (2023) - p. 156408 , 2023
Link:
https://doi.org/10.1016/..
?
2
Cost-effectiveness analysis of transarterial chemoembolizat..:
He, Ying
;
Lin, Wangchun
;
Cai, Zhongjie
...
Frontiers in Pharmacology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
3
Cost-effectiveness analysis of dostarlimab plus carboplatin..:
You, Maojin
;
Zeng, Xiaoling
;
Zhang, Jinrong
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
4
Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 a..:
Huang, Yufan
;
You, Maojin
;
Wu, Qundan
.
Frontiers in Pharmacology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
5
Table1_Cost-effectiveness analysis of transarterial chemoem..:
Ying He
;
Wangchun Lin
;
Zhongjie Cai
...
doi:10.3389/fphar.2023.1219694.s001. , 2023
Link:
https://doi.org/10.3389/..
?
6
Cost-effectiveness analysis of transarterial chemoembolizat..:
He, Ying
;
Lin, Wangchun
;
Cai, Zhongjie
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512705/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
Cost-effectiveness analysis of dostarlimab plus carboplatin..:
You, Maojin
;
Zeng, Xiaoling
;
Zhang, Jinrong
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507332/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 a..:
Huang, Yufan
;
You, Maojin
;
Wu, Qundan
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500349/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
Cost-effectiveness analysis of dostarlimab plus carboplatin..:
Maojin You
;
Xiaoling Zeng
;
Jinrong Zhang
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267322/full. , 2023
Link:
https://doi.org/10.3389/..
?
10
Cost-effectiveness analysis of transarterial chemoembolizat..:
Ying He
;
Wangchun Lin
;
Zhongjie Cai
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1219694/full. , 2023
Link:
https://doi.org/10.3389/..
?
11
Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 a..:
Yufan Huang
;
Maojin You
;
Qundan Wu
.
https://www.frontiersin.org/articles/10.3389/fphar.2023.1238009/full. , 2023
Link:
https://doi.org/10.3389/..
?
12
Table1_Cost-effectiveness analysis of zolbetuximab plus mFO..:
Yufan Huang
;
Maojin You
;
Qundan Wu
.
doi:10.3389/fphar.2023.1238009.s001. , 2023
Link:
https://doi.org/10.3389/..
?
13
DataSheet_1_Cost-effectiveness analysis of dostarlimab plus..:
Maojin You
;
Xiaoling Zeng
;
Jinrong Zhang
...
doi:10.3389/fimmu.2023.1267322.s001. , 2023
Link:
https://doi.org/10.3389/..
?
14
Cost-effectiveness analysis of sintilimab plus chemotherapy..:
You, Maojin
;
Huang, Yufan
;
Cai, Zhongjie
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
15
Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplati..:
Chen, Ruijia
;
Zhang, Yalan
;
Lin, Kongying
...
Frontiers in Pharmacology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
1-15
